drugset / Trial / NCT02836418
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)
NaSingle-groupOpen-labelTreatment
Summary
ATYR1940-C-006 is a multi-national, multicenter study being conducted at centers in the United States (US) and Europe who participated in Study ATYR1940-C-003 (Stage 1 only) or Study ATYR1940-C-004 (that is, the parent studies).
Timeline
- Start
- 2016-07-13
- Primary completion
- 2017-04-18
- Completion
- 2017-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATYR1940 | Unknown | 3 mg/kg | Intravenous |